- Author:
Shuk Ying CHAN
1
;
Susan E. PROCKOP
;
Farid BOULAD
;
Genovefa A. PAPANICOLAOU
;
Yeon Joo LEE
Author Information
- Publication Type:Case Report
- From:Infection and Chemotherapy 2021;53(3):572-577
- CountryRepublic of Korea
- Language:English
- Abstract: Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report four pediatric HCT recipients with d-ADV treated successfully with BCV.